In the latest discussion, the hosts tackle the mixed performance of global stocks and Didi’s messy exit from U.S. markets. The cryptocurrency scene faces turmoil, especially with the Beanstalk exploit raising concerns. Zambian startup Union54 impresses with its $12 million funding, while the competition in India's food delivery market heats up. The hosts delve into the pros and cons of poison pills as a defense against hostile takeovers, highlighting investor contradictions, especially among those backing dual-class shares. A live show is coming up too!
09:04
forum Ask episode
web_stories AI Snips
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
insights INSIGHT
Crypto and Earnings
Major crypto tokens are down, but the market is mostly calm.
Earnings season is coming up, with big tech companies like Netflix, Tesla, Google, and Apple reporting.
question_answer ANECDOTE
Didi Delisting
Didi will vote on delisting from the NYSE and will not list elsewhere until that is complete.
Investors are not happy, and Didi's share value has plummeted.
question_answer ANECDOTE
Beanstalk Exploit
Beanstalk, a decentralized credit-based stablecoin, was exploited for $182 million.
The attacker used a flash loan to manipulate governance tokens and steal funds.
Get the Snipd Podcast app to discover more snips from this episode
Every Monday, Grace and Alex scour the news and record notes on what’s going on to kick off the week.
We are sitting on the precipice of a very busy few weeks, so let's get right to work!
Stocks are mixed around the world to start the day, cryptos are off a little more but nothing too scary.
Didi will vote on leaving the US public markets this May, and has promised to not list anywhere else in the interim. This saga is nearly behind us, but what a mess it will leave in its wake.
The Beanstalk exploit was bad news this weekend, but my hunch is that so long as votes are tied to economic might, many neat ideas in crypto-land will remain open to exploit.
Finally, it seems that some private-market investors are not stoked about poison pills, a defensive setup by public companies to prevent a hostile takeover. Which makes me laugh, as dual-class shares that many VCs either back, or at least help fund amongst hot startups are similar in that they are also designed to prevent changes of control.
To close, we have a live show this week! Yes, a live show. So come hang out with us on Thursday as we record our Friday episode!
Credits: Equity is produced by Theresa Loconsolo with editing by Kell. Bryce Durbin is our Illustrator. We'd also like to thank the audience development team and Henry Pickavet, who manages TechCrunch audio products.